These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7528384)

  • 21. Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy.
    Javlé P; Jenkins SA; Machin DG; Parsons KF
    J Urol; 1998 Nov; 160(5):1713-7. PubMed ID: 9783938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assessment of medical treatment for benign prostatic hyperplasia (BPH).
    Roehrborn CG
    Prog Clin Biol Res; 1994; 386():175-90. PubMed ID: 7528385
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel canine model of partial outlet obstruction secondary to prostatic hypertrophy.
    Broderick GA; Longhurst PA; Juniewicz PE; Wein AJ; Levin RM
    World J Urol; 1994; 12(5):245-8. PubMed ID: 7532514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of flowmetry in nodular hyperplasia of the prostate].
    Rodrigues Netto N; Pires Fakiani E; Caserta Lemos G
    Arch Esp Urol; 1983; 36(2):133-8. PubMed ID: 6194762
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Obstruction following surgical repair of female stress urinary incontinence. Diagnosis and treatment].
    Romero Maroto J; Prieto Chaparro L; López López C; Quilez Fenoll JM; Rodríguez Fernández E
    Arch Esp Urol; 2002 Nov; 55(9):1107-14. PubMed ID: 12564070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Etiology and treatment of bladder spasm associated with benign prostatic hyperplasia].
    Zhao J; He DL; Liu RM; Wang MZ; Wang XN; Xing JP; Nan XY
    Zhonghua Nan Ke Xue; 2005 Apr; 11(4):275-7. PubMed ID: 15921258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative surgical treatments for obstructive BPH: balloons and stents.
    Vale JA; Holmes SA; Kirby RS
    Prog Clin Biol Res; 1994; 386():577-93. PubMed ID: 7528428
    [No Abstract]   [Full Text] [Related]  

  • 29. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
    Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
    J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The course and limitation of medical treatment for benign prostatic hyperplasia].
    Kitagawa N; Akakura K; Akimoto S; Shimazaki J; Murakami S; Ishikawa T; Kataumi S; Sotoma T; Takagishi H; Kitamura Y
    Hinyokika Kiyo; 1994 Sep; 40(9):781-8. PubMed ID: 7528462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Seki N; Nomura H; Yamaguchi A; Naito S
    J Urol; 2008 Sep; 180(3):1024-8; discussion 1028-9. PubMed ID: 18639299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transurethral microwave thermotherapy versus transurethral resection for BPH.
    Dahlstrand C; Waldén M; Geirsson G; Sommar S; Pettersson S
    Prog Clin Biol Res; 1994; 386():455-61. PubMed ID: 7528415
    [No Abstract]   [Full Text] [Related]  

  • 33. [A comparative study of different urodynamic methods used in the diagnosis of lower urinary tract obstruction in men].
    Virseda Chamorro M; Salinas Casado J; Adot Zurbano JM; Esteban Fuertes M; Samblas García R; Resel Estévez L
    Arch Esp Urol; 1995 May; 48(4):369-80. PubMed ID: 7598548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach.
    Ballert KN; Biggs GY; Isenalumhe A; Rosenblum N; Nitti VW
    J Urol; 2009 Feb; 181(2):679-84. PubMed ID: 19091337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urodynamic and clinical effects of noninvasive and minimally invasive treatments in elderly men with lower urinary tract symptoms stratified according to the grade of obstruction.
    Witjes WP; Robertson A; Rosier PF; Neal DE; Debruyne FM; de la Rosette JJ
    Urology; 1997 Jul; 50(1):55-61. PubMed ID: 9218019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic stents for benign prostatic hyperplasia.
    Klein LT; Kaplan SA
    J Long Term Eff Med Implants; 1997; 7(1):101-14. PubMed ID: 10168540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-TURP incontinence.
    Diller LM
    Urol Nurs; 2000 Feb; 20(1):54. PubMed ID: 11998042
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Reich O
    Eur Urol; 2008 Oct; 54(4):908. PubMed ID: 18502566
    [No Abstract]   [Full Text] [Related]  

  • 40. Editorial comment on: Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.
    Seitz M
    Eur Urol; 2008 Oct; 54(4):909-10. PubMed ID: 18502567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.